Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Watch out for 800% ??
LoL . Good point .
Regen will be current any moments https://www.sec.gov/edgar/browse/?CIK=1589150&owner=exclude
100% agree . In a few days we should see PPS range $0.15 - 0.25
Great . But keep in the mind that Koss also said that company not going to any buyout or mergers. He said clear that company will go by they own. So . Is hard to believe. Maybe Koss have already private placements. To start trials they have to get approval from FDA and have budget at list $60 mil —- $ 120 mil. Just for start. Koss is not talking s…t what backup he have if he have any .
Guys and girls . Current status not guarantee huge run above Moon. After current , Koss have to prove business plan for Regen. Depends what is in the shirt sleeve price can explode or not . Koss, maybe is time to open mouth and start talk to investors .
Correct. Nobody know exactly what game Koss is playing. Before current status we have only questions without answer. Quo vadis Koss?
Regen shareholders . Target $ 0.10 small profit but safe . $ 0.25 not bad profit . $ 0.75 good profit $ 1.25 great profit . $ 3.75 welcome to millionaire club . Anything below $ 0.10 is just stupid sell and loose opportunity to make a lifetime profit .
Sid. With all my respect. Regen is in the progress to buyout because they so far can’t take advantage to target they own pipeline. They don’t have a billion budget for that and for Koss time is money. For sure he don’t have time to wait a few years . Usually five years or more. But buyout can be a best deal for company. IMO Koss will sell company in the a few weeks or months and he will move on to the next company. I think he have already proposal and he is on the rush to get current . Many of the small company did that . Here you are Cancer, rare disease and, to a lesser extent, central nervous system players are targets that match up most closely with prospective buyers. Meanwhile, the scale of the industry’s product pipeline is at record highs, creating a big shop window for buyers to choose from.
Jared Holz, CPA, Healthcare Equity Strategy, Jefferies LLC—who was instrumental in helping Fierce Biotech come up with this year’s shortlist—says that while 2019 was remarkable for large-scale acquisitions, in 2020 “our sense is mid-size deals are more likely.”
He expects to see transactions in the $5 billion to $10 billion range and says many biotech companies who have often been featured on takeout lists—such as Seattle Genetics, Vertex Pharma and Regeneron—are likely too large in size now, and the window for any such deal has passed.
Among others on those lists, Alexion, BioMarin and Neurocrine Biosciences are probably at the higher end of the market-cap spectrum in terms of companies that could see themselves acquired by firms of greater size.
Looking a little beyond the companies on our top 10 list, other biotechs that could be the subject of deals include Arena Pharma, Avadel Pharma, Biohaven, Blueprint Medicines, Incyte, Karyopharm Therapeutics, Retrophin, SAGE Therapeutics, Sarepta, and uniQure.
Holz thinks the following large-cap firms are among those most likely to be active in M&A in the coming months: Amgen, Biogen, Bristol Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, and Sanofi.
Many of those companies are either already restructuring or are in need of it, and have management actively engaging with M&A as a tool for business development.
Limited will be trade the same way as current. Restrictions will eliminates all STOP, Cross bones , and all shares of companies not existing any more but traders holding shares at they accounts. Finally crooked CEOs and wealthy pumpers will get kicked in the a…from market. RGBP will be safe to trade. Company have actual status at Bio industry. Also please check out video about huge potential for Regen Biopharma
Wow. Good find .
100% agree .
So, you’re lucky. My micro SSD rider never show up . Order was just for a few bucks. Not a big deal, but I don’t trust anymore for WISH platform. The same bs like Alibaba platform .
LoL . You sold then you lost .
Are you guys have a healthy brains ? You will kick your asses in next days.
To many smucks selling for profit . Stupid .
Looks like RGBP ready to pass $ 0.10
LOL.This baby will fly tomorrow and don’t needed 37 day . After 37 days RGBP will be in dollar land. Take care
Are you ok??? Never seen buyout relays at IP. LOL ,LOL,LOL
Cover suckers today . Monday will be to late.
I know personally this young woman. She’s China beautiful girl and when she show me her followers I was in shock. Yes I was talking with her about Regen and she told me that can be a life opportunity to spend a few zeros to invest . Of course I didn’t ask her to invest . But is good to share her opinion. She’s smart, intelligent and mega rich.
Not to much change . L2 B 0.0341 A 0.0344
Wonder what can happen for PPS if person with one million followers from Insta will ask gang to buy RGBP for $1000 each follower. I think that dollar land can be a piece of cake. . So . Stay tuned.
I think that all RGBP investors /traders will see a roller coaster here. Many will fly away and long will stay up to dollar land. Mostly small investors will be happy with three zeros profit. Professionals traders will stay until six zeros profit .
If this happens here. I’ll move my basements office above attic LOL
First $ 3.75 . This is needed to safe upgrade to Nasdaq. If buyout $ 9.00 PPS
Finally we’re climbing over $0.03 wall . Good job boys and girls .
Chit. Traders to weak to destroy $0.03 wall. What da heck is going on with you guys ? Is everybody broken? Or nobody like to empty piggy bank ?
If PPS will not rise at limited status then will not jump at current status .
L2 don’t showing to much enthusiasm for Koss.
Well. If insiders are really active then PPS already should be above $0.25 . What da hell is truly going on ? Nobody know except Koss
If Koss is negotiating buyout then next a few days status must be current. No other explanation why Koss is at rush and paying huge money for team who’s working 24 hr at SEC fillings.
This is great movement by company. Now we have more clear view what’s going on. I think that after current status we can get final answer for questions what Koss hides in shirt sleeve. I have hope that can be a joker.
I don’t think that MM. Must be Koss or some players hiring by big pharma who like to buyout Regen Biopharma. For sure not MM.
People desperately waiting to pass PPS $ 0.03 . Why after so many filings and last PR price can’t pass that wall ? Only two reason. Weak buying pressure and peeps don’t trust to much Koss. Mostly peeps sitting at fence and waiting. What is very interesting that before PR or fillings buy vs sell is almost equal. But right after news or SEC report buying is a little and dump is three or more times bigger. Is the MM manipulations? I don’t think so . Dilution? I don’t think so . What da heck is that ? I don’t know. Looks like some wealthy gang holding billion shares and working for big pharma company to hold price down before buyout. Is no other explanation why RGBP was at easy and quick run up to $ 0.08 at fake rumor about merger and now after so many reports and a good PR dance about own tail.
RGBP is a one of the biggest shorted stock at OTC market . 785,564,543 Shares shorted . Squeezing will take PPS to dollars .
For today RGBP short volume is almost 1 billion shares . Exactly 785,564,543 shorted Squeeze can be a huge !!!